Active Shortage Injection Endocrinology/Metabolism
Sodium Bicarbonate Injection · 3,481 days since initial FDA posting
Brand: SODIUM BICARBONATE
FDA lists Sodium Bicarbonate Injection as Active Shortage (Hospira, Inc., a Pfizer Company).
Availability on file: Available
Sodium Bicarbonate Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Sodium Bicarbonate Injection
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Injection
- Presentation
- Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-14)
- Package NDC
- 0409-6625-14
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Mar 1, 2017
- Last Updated
- Mar 13, 2026
- Therapeutic Category
- Endocrinology/Metabolism, Gastroenterology, Pediatric
Row fields from the FDA Drug Shortages database via openFDA.
Nearby, Other Sodium Shortage Records
Sodium Bicarbonate Injection
Fresenius Kabi USA, LLC
Injection
Sodium Bicarbonate Injection
Fresenius Kabi USA, LLC
Injection
Sodium Bicarbonate Injection
Hospira, Inc., a Pfizer Company
Injection
Sodium Bicarbonate Injection
Hospira, Inc., a Pfizer Company
Injection
Sodium Bicarbonate Injection
Hospira, Inc., a Pfizer Company
Injection
Sodium Bicarbonate Injection
Hospira, Inc., a Pfizer Company
Injection